IWA
CTIC

Intercontinental Wealth Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Intercontinental Wealth Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14
Closed – – 334
2019
Q4 		$0 Hold
14
– – ﹤0.01% 438
2019
Q3 		$0 Hold
14
– – ﹤0.01% 452
2019
Q2 		$0 Hold
14
– – ﹤0.01% 445
2019
Q1 		$0 Hold
14
– – ﹤0.01% 467
2018
Q4 		$0 Buy
+14
New +$23 ﹤0.01% 456

Other funds holding CTIC

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return